Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

228
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
228
Human Genetics01:28

Human Genetics

566
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
566

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A Bayesian framework for longitudinal EHR and genetic discovery.

Nature·2026
Same author

Joint Effects of Early Pandemic Containment Policies on Anxiety in the United States.

medRxiv : the preprint server for health sciences·2026
Same author

Phenotyping antidepressant treatment response with deep learning in electronic health records.

Translational psychiatry·2026
Same author

Molecular genetic influences on sustained attention and executive processes and their links with psychopathology in the AFFECT study.

Molecular psychiatry·2026
Same author

Mapping the genetic architecture of human cortical expansion and its links to neuropsychiatric disorders.

bioRxiv : the preprint server for biology·2026
Same author

GWAS analysis of a depression cohort defined by an EHR-phenotyping algorithm reveals the role of immune regulations in depression risk.

Frontiers in genetics·2026

相关实验视频

Updated: Jun 29, 2025

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.3K

为第二阶段抑郁症治疗优化精准医学:一种机器学习方法.

Joshua Curtiss1, Jordan W Smoller2, Paola Pedrelli1

  • 1Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.

Psychological medicine
|March 27, 2024
PubMed
概括

机器学习可以预测抑郁症治疗的成功. 整体模型显示认知治疗的准确性高于药物治疗,为个性化抑郁症护理提供了希望.

关键词:
抑郁 抑郁症 抑郁症 抑郁症 是一种机器学习是机器学习.精准医学是一门精准医学.

更多相关视频

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.5K

相关实验视频

Last Updated: Jun 29, 2025

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.3K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.5K

科学领域:

  • 精神病学和计算科学 精神病学和计算科学
  • 医疗保健中的机器学习

背景情况:

  • 标准抗抑郁药单一治疗在超过三分之二的抑郁症患者中未能达到缓解.
  • 目前选择的第二阶段抑郁症治疗方法严重依赖于临床直觉,导致延迟和患者负担.
  • 建议采用整体机器学习方法来提高第二阶段治疗缓解的预测准确性.

研究的目的:

  • 开发和评估一个整体机器学习模型,用于预测接受第二阶段护理的抑郁症患者的治疗缓解.
  • 评估机器学习在预测对各种第二阶段治疗策略的反应中的准确性.

主要方法:

  • 利用了STAR*D第二级数据集中的1439名患者的数据,随机分配到七种第二步治疗.
  • 采用集体机器学习模型,结合多个算法,通过嵌套交叉验证进行评估.
  • 包括155个预测变量,包括临床和人口统计指标.

主要成果:

  • 组合模型在不同的第二步治疗中显示出不同的预测性能,AUC值从0.51到0.82.8不等.
  • 预测缓解是认知疗法最准确的 (AUC = 0.82).
  • 其他药物和联合治疗选择的预测准确性较低 (AUC = 0.51-0.66).

结论:

  • 整体机器学习显示出预测第二阶段抑郁症治疗有效性的前景.
  • 预测准确性因治疗类型而异,与药物治疗相比,行为干预的预测准确性更高.
  • 未来的研究应该探索额外的预测模式,以改善对治疗反应的预测.